Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant

NCT02232178 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Hernioplasty

Interventions

DRUG: 2 100mg Xaracoll implants
DRUG: 3 100mg Xaracoll implants
DRUG: 150mg Bupivacaine HCl injection

Sponsor

Innocoll

Collaborators

[object Object]